Report Detail
Global Angiopoietin 1 Receptor Market Insights, Forecast to 2025
- RnM2849479 |
- 01 February, 2019 |
- Global |
- 110 Pages |
- QYResearch |
- Pharma & Healthcare
The global Angiopoietin 1 Receptor market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Angiopoietin 1 Receptor market based on company, product type, end user and key regions.
This report studies the global market size of Angiopoietin 1 Receptor in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Angiopoietin 1 Receptor in these regions.
This research report categorizes the global Angiopoietin 1 Receptor market by top players/brands, region, type and end user. This report also studies the global Angiopoietin 1 Receptor market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Aerpio Therapeutics, Inc.
Deciphera Pharmaceuticals, LLC
Eddingpharm
Exelixis, Inc.
Pfizer Inc.
PharmAbcine, Inc.
Sanofi
Teva Pharmaceutical Industries Ltd.
Market size by Product
MAN-01
PMC-001
AP-185
ARP-1536
Others
Market size by End User
Bladder Cancer
Neuroendocrine Tumors
Ovarian Cancer
Ureter Cancer
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Angiopoietin 1 Receptor market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Angiopoietin 1 Receptor market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Angiopoietin 1 Receptor companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Angiopoietin 1 Receptor submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Angiopoietin 1 Receptor are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Angiopoietin 1 Receptor market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Angiopoietin 1 Receptor Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Angiopoietin 1 Receptor Market Size Growth Rate by Product
- 1.4.2 MAN-01
- 1.4.3 PMC-001
- 1.4.4 AP-185
- 1.4.5 ARP-1536
- 1.4.6 Others
- 1.5 Market by End User
- 1.5.1 Global Angiopoietin 1 Receptor Market Size Growth Rate by End User
- 1.5.2 Bladder Cancer
- 1.5.3 Neuroendocrine Tumors
- 1.5.4 Ovarian Cancer
- 1.5.5 Ureter Cancer
- 1.5.6 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Angiopoietin 1 Receptor Market Size
- 2.1.1 Global Angiopoietin 1 Receptor Revenue 2014-2025
- 2.1.2 Global Angiopoietin 1 Receptor Sales 2014-2025
- 2.2 Angiopoietin 1 Receptor Growth Rate by Regions
- 2.2.1 Global Angiopoietin 1 Receptor Sales by Regions
- 2.2.2 Global Angiopoietin 1 Receptor Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Angiopoietin 1 Receptor Sales by Manufacturers
- 3.1.1 Angiopoietin 1 Receptor Sales by Manufacturers
- 3.1.2 Angiopoietin 1 Receptor Sales Market Share by Manufacturers
- 3.1.3 Global Angiopoietin 1 Receptor Market Concentration Ratio (CR5 and HHI)
- 3.2 Angiopoietin 1 Receptor Revenue by Manufacturers
- 3.2.1 Angiopoietin 1 Receptor Revenue by Manufacturers (2014-2019)
- 3.2.2 Angiopoietin 1 Receptor Revenue Share by Manufacturers (2014-2019)
- 3.3 Angiopoietin 1 Receptor Price by Manufacturers
- 3.4 Angiopoietin 1 Receptor Manufacturing Base Distribution, Product Types
- 3.4.1 Angiopoietin 1 Receptor Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Angiopoietin 1 Receptor Product Type
- 3.4.3 Date of International Manufacturers Enter into Angiopoietin 1 Receptor Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Angiopoietin 1 Receptor Sales by Product
- 4.2 Global Angiopoietin 1 Receptor Revenue by Product
- 4.3 Angiopoietin 1 Receptor Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Angiopoietin 1 Receptor Breakdown Data by End User
6 North America
- 6.1 North America Angiopoietin 1 Receptor by Countries
- 6.1.1 North America Angiopoietin 1 Receptor Sales by Countries
- 6.1.2 North America Angiopoietin 1 Receptor Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Angiopoietin 1 Receptor by Product
- 6.3 North America Angiopoietin 1 Receptor by End User
7 Europe
- 7.1 Europe Angiopoietin 1 Receptor by Countries
- 7.1.1 Europe Angiopoietin 1 Receptor Sales by Countries
- 7.1.2 Europe Angiopoietin 1 Receptor Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Angiopoietin 1 Receptor by Product
- 7.3 Europe Angiopoietin 1 Receptor by End User
8 Asia Pacific
- 8.1 Asia Pacific Angiopoietin 1 Receptor by Countries
- 8.1.1 Asia Pacific Angiopoietin 1 Receptor Sales by Countries
- 8.1.2 Asia Pacific Angiopoietin 1 Receptor Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Angiopoietin 1 Receptor by Product
- 8.3 Asia Pacific Angiopoietin 1 Receptor by End User
9 Central & South America
- 9.1 Central & South America Angiopoietin 1 Receptor by Countries
- 9.1.1 Central & South America Angiopoietin 1 Receptor Sales by Countries
- 9.1.2 Central & South America Angiopoietin 1 Receptor Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Angiopoietin 1 Receptor by Product
- 9.3 Central & South America Angiopoietin 1 Receptor by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Angiopoietin 1 Receptor by Countries
- 10.1.1 Middle East and Africa Angiopoietin 1 Receptor Sales by Countries
- 10.1.2 Middle East and Africa Angiopoietin 1 Receptor Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Angiopoietin 1 Receptor by Product
- 10.3 Middle East and Africa Angiopoietin 1 Receptor by End User
11 Company Profiles
- 11.1 Aerpio Therapeutics, Inc.
- 11.1.1 Aerpio Therapeutics, Inc. Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Aerpio Therapeutics, Inc. Angiopoietin 1 Receptor Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Aerpio Therapeutics, Inc. Angiopoietin 1 Receptor Products Offered
- 11.1.5 Aerpio Therapeutics, Inc. Recent Development
- 11.2 Deciphera Pharmaceuticals, LLC
- 11.2.1 Deciphera Pharmaceuticals, LLC Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Deciphera Pharmaceuticals, LLC Angiopoietin 1 Receptor Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Deciphera Pharmaceuticals, LLC Angiopoietin 1 Receptor Products Offered
- 11.2.5 Deciphera Pharmaceuticals, LLC Recent Development
- 11.3 Eddingpharm
- 11.3.1 Eddingpharm Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Eddingpharm Angiopoietin 1 Receptor Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Eddingpharm Angiopoietin 1 Receptor Products Offered
- 11.3.5 Eddingpharm Recent Development
- 11.4 Exelixis, Inc.
- 11.4.1 Exelixis, Inc. Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Exelixis, Inc. Angiopoietin 1 Receptor Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Exelixis, Inc. Angiopoietin 1 Receptor Products Offered
- 11.4.5 Exelixis, Inc. Recent Development
- 11.5 Pfizer Inc.
- 11.5.1 Pfizer Inc. Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Pfizer Inc. Angiopoietin 1 Receptor Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Pfizer Inc. Angiopoietin 1 Receptor Products Offered
- 11.5.5 Pfizer Inc. Recent Development
- 11.6 PharmAbcine, Inc.
- 11.6.1 PharmAbcine, Inc. Company Details
- 11.6.2 Company Business Overview
- 11.6.3 PharmAbcine, Inc. Angiopoietin 1 Receptor Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 PharmAbcine, Inc. Angiopoietin 1 Receptor Products Offered
- 11.6.5 PharmAbcine, Inc. Recent Development
- 11.7 Sanofi
- 11.7.1 Sanofi Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Sanofi Angiopoietin 1 Receptor Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Sanofi Angiopoietin 1 Receptor Products Offered
- 11.7.5 Sanofi Recent Development
- 11.8 Teva Pharmaceutical Industries Ltd.
- 11.8.1 Teva Pharmaceutical Industries Ltd. Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Teva Pharmaceutical Industries Ltd. Angiopoietin 1 Receptor Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Teva Pharmaceutical Industries Ltd. Angiopoietin 1 Receptor Products Offered
- 11.8.5 Teva Pharmaceutical Industries Ltd. Recent Development
12 Future Forecast
- 12.1 Angiopoietin 1 Receptor Market Forecast by Regions
- 12.1.1 Global Angiopoietin 1 Receptor Sales Forecast by Regions 2019-2025
- 12.1.2 Global Angiopoietin 1 Receptor Revenue Forecast by Regions 2019-2025
- 12.2 Angiopoietin 1 Receptor Market Forecast by Product
- 12.2.1 Global Angiopoietin 1 Receptor Sales Forecast by Product 2019-2025
- 12.2.2 Global Angiopoietin 1 Receptor Revenue Forecast by Product 2019-2025
- 12.3 Angiopoietin 1 Receptor Market Forecast by End User
- 12.4 North America Angiopoietin 1 Receptor Forecast
- 12.5 Europe Angiopoietin 1 Receptor Forecast
- 12.6 Asia Pacific Angiopoietin 1 Receptor Forecast
- 12.7 Central & South America Angiopoietin 1 Receptor Forecast
- 12.8 Middle East and Africa Angiopoietin 1 Receptor Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Angiopoietin 1 Receptor Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Angiopoietin 1 Receptor . Industry analysis & Market Report on Angiopoietin 1 Receptor is a syndicated market report, published as Global Angiopoietin 1 Receptor Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Angiopoietin 1 Receptor market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
